June 6th, 2025 • Blogs Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Aff… Our guest post, “Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Affordability,” is feature…
May 13th, 2025 • News Cracking the Code on Copay: From Mitigation to Mastery Our article, “Cracking the Code on Copay – From Mitigation to Mastery” by Bryan Dennison, MBA, Senior VP of Sales …
April 1st, 2025 • Uncategorized Paysign is a Supporting Sponsor at the Pharmaceutical Compliance Congress 20… Paysign will be a supporting sponsor at the upcoming Pharmaceutical Compliance Congress in McLean, VA on April 28-30, 20…
March 4th, 2025 • Events Paysign to Attend Asembia Specialty Pharmacy Summit, April 27-May 01, 2025 Paysign will be attending the 2025 Asembia Specialty Pharmacy Summit, taking place April 27-May 01, in Las Vegas. The Pa…
February 26th, 2025 • Events Paysign is a Sponsor at ACCESS USA 2025, March 18-20, Philadelphia, PA Paysign is excited to be a supporting sponsor at the ACCESS USA event, Accelerating Access, Partnerships and Collaborat…
February 4th, 2025 • News Paysign Announces 2024 Performance Analysis of Patient Affordability Solutio… Proprietary Feature Demonstrates Advanced Accuracy in Mitigating Copay Maximizers HENDERSON, Nev. – February 4, 2025 …
October 31st, 2024 • Events Paysign to Sponsor the Patient Support Services Congress, Philadelphia, PA Paysign has added to their on-going sponsorship of Informa Connect Life Sciences events with the Patient Support Service…
October 23rd, 2024 • Events Paysign Will Sponsor the PPTA Plasma Protein Forum, Washington, D.C. Paysign will once again sponsor the Plasma Protein Therapeutic Association Forum in Washington, D.C. on November 19-20, …
October 22nd, 2024 • Events Paysign is a Sponsor at the Copay, Reimbursement and Access Congress, Philad… Paysign is a Sponsor and Participant at the Copay, Reimbursement and Access Congress, Philadelphia, PA Paysign is a spon…
September 10th, 2024 • News Lawmakers Crack Down on Pharmaceutical Middlemen Driving High Prices Recent Congressional Hearings Expose Weak and Vague Arguments From PBM Executives We may finally have an answer (for now…
